RankingsPricing
  1. US-listed companies
  2. TAKEDA PHARMACEUTICAL CO LTD
  3. Income statement

TAKEDA PHARMACEUTICAL CO LTDTAK

Market cap
P/E ratio
SummaryFinancials
Income statementBalance sheetCash flowOther
2019/032020/032021/032022/032023/032024/03
Revenue2,097,224-3,197,8123,569,0064,027,4784,263,762
Revenue growth (%)---
Research & development368,298-455,833526,087633,325729,924
Operating margin (%)-
Operating income 204,969-509,269460,844490,505214,075
Income before tax 94,896-366,235302,571375,09052,791
Pretax margin (%)4.5-11.58.59.31.2
Net income 109,01444,290376,171230,166317,038144,197
Net income margin (%)-
Raw aggregated data